Skill Checkup: Suboptimally Treated Relapsing-Remitting Multiple Sclerosis (RRMS)

Christopher Luzzio, MD


January 26, 2022

The clinical and MRI findings in this case are consistent with a diagnosis of optic neuritis secondary to MS. The patient is treated with intravenous corticosteroids. Other treatment options for optic neuritis include oral corticosteroids and immunomodulatory therapy, such as plasmapheresis.

AION occurs in individuals 50 years of age or older; moreover, pain is only present in less than 10% of patients. Therefore, AION is less probable in this case.

LHON primarily affects young men (up to 90% of cases). Therefore, this disease is an unlikely cause for this patient's symptoms.

Compressive toxic/nutritional optic neuropathy is characterized by a gradual onset of vision loss over months, as opposed to the acute onset that is seen with optic neuritis.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.